{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:18:07Z","timestamp":1791728287116,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00125-011-2274-6","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T15:14:40Z","timestamp":1313594080000},"page":"2900-2910","source":"Crossref","is-referenced-by-count":67,"title":["Altered endocannabinoid signalling after a high-fat diet in Apoe \u2212\/\u2212 mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance"],"prefix":"10.1007","volume":"54","author":[{"given":"A.","family":"Bartelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ligresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Toedter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Scheja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.ATV.0000201282.64751.47","volume":"26","author":"J Heeren","year":"2006","unstructured":"Heeren J, Beisiegel U, Grewal T (2006) Apolipoprotein E recycling. Implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 26:442\u2013448","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2274_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.12.027","volume":"211","author":"GM Dallinga-Thie","year":"2010","unstructured":"Dallinga-Thie GM, Franssen R, Mooij HL et al (2010) The metabolism of triacylglycerol-rich lipoproteins revisited: new players, new insight. Atherosclerosis 211:1\u20138","journal-title":"Atherosclerosis"},{"key":"2274_CR3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.0000128849.12617.f4","volume":"24","author":"KS Meir","year":"2004","unstructured":"Meir KS, Leitersdorf E (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse. A decade of progress. Arterioscler Thromb Vasc Biol 24:1006\u20131014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl","key":"2274_CR4","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res 50(Suppl):S183\u2013S188","journal-title":"J Lipid Res"},{"key":"2274_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","volume":"48","author":"K Wouters","year":"2008","unstructured":"Wouters K, van Gorp PJ, Bieghs V et al (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474\u2013486","journal-title":"Hepatology"},{"key":"2274_CR6","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.atherosclerosis.2007.06.012","volume":"195","author":"J Joven","year":"2007","unstructured":"Joven J, Rull A, Ferr\u00e9 N et al (2007) The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 195:e85\u2013e92","journal-title":"Atherosclerosis"},{"key":"2274_CR7","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1016\/S0021-9258(18)99263-X","volume":"266","author":"R Zechner","year":"1991","unstructured":"Zechner R, Moser R, Newman TC, Fried SK, Breslow JL (1991) Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem 266:10583\u201310588","journal-title":"J Biol Chem"},{"key":"2274_CR8","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.2337\/db06-0354","volume":"55","author":"ZH Huang","year":"2006","unstructured":"Huang ZH, Reardon CA, Mazzone T (2006) Endogenous ApoE expression modulates adipocyte triacylglycerol content and turnover. Diabetes 55:3394\u20133402","journal-title":"Diabetes"},{"key":"2274_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/db06-0144","volume":"56","author":"J Gao","year":"2007","unstructured":"Gao J, Katagiri H, Ishigaki Y et al (2007) Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 56:24\u201333","journal-title":"Diabetes"},{"key":"2274_CR10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bone.2010.07.002","volume":"47","author":"A Bartelt","year":"2010","unstructured":"Bartelt A, Beil FT, Schinke T et al (2010) Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl\/6 mice: modulation by diet-induced obesity. Bone 47:736\u2013745","journal-title":"Bone"},{"key":"2274_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","volume":"1","author":"K Maeda","year":"2005","unstructured":"Maeda K, Cao H, Kono K et al (2005) Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107\u2013119","journal-title":"Cell Metab"},{"key":"2274_CR12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","volume":"134","author":"H Cao","year":"2008","unstructured":"Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134:933\u2013944","journal-title":"Cell"},{"key":"2274_CR13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1262-3636(08)74604-4","volume":"34","author":"A Mallat","year":"2008","unstructured":"Mallat A, Lotersztajn S (2008) Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. Diabetes Metab 34:680\u2013684","journal-title":"Diabetes Metab"},{"key":"2274_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beem.2008.10.009","volume":"23","author":"P Caraceni","year":"2009","unstructured":"Caraceni P, Domenicali M, Giannone F, Bernardi M (2009) The role of the endocannabinoid system in liver diseases. Best Pract Res Clin Endocrinol Metab 23:65\u201377","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2274_CR15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2009.197","volume":"5","author":"V Marzo Di","year":"2009","unstructured":"Di Marzo V, Despr\u00e9s JP (2009) CB1 antagonists for obesity\u2014what lessons have we learned from rimonabant? Nat Rev Endocrinol 5:633\u2013638","journal-title":"Nat Rev Endocrinol"},{"key":"2274_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/oby.2007.106","volume":"16","author":"KM Starowicz","year":"2008","unstructured":"Starowicz KM, Cristino L, Matias I et al (2008) Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 16:553\u2013565","journal-title":"Obesity"},{"key":"2274_CR17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, DePetrillo M, Pacher P et al (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298\u20131305","journal-title":"J Clin Invest"},{"key":"2274_CR18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/ATVBAHA.108.176362","volume":"29","author":"JP Despr\u00e9s","year":"2009","unstructured":"Despr\u00e9s JP, Ross R, Boka G, Alm\u00e9ras N, Lemieux I (2009) ADAGIO-Lipids Investigators. Effect of rimonabant on the high-triacylglycerol\/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol 29:416\u2013423","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2274_CR19","doi-asserted-by":"crossref","first-page":"14561","DOI":"10.1073\/pnas.0807232105","volume":"105","author":"MA Ruby","year":"2008","unstructured":"Ruby MA, Nomura DK, Hudak CS et al (2008) Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triacylglycerol-rich lipoproteins. Proc Natl Acad Sci U S A 105:14561\u201314566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2274_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ijo.2009.262","volume":"34","author":"C Touri\u00f1o","year":"2010","unstructured":"Touri\u00f1o C, Oveisi F, Lockney J, Piomelli D, Maldonado R (2010) FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes (Lond) 34:557\u2013568","journal-title":"Int J Obes (Lond)"},{"key":"2274_CR21","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman D, Liu J, Zhou L et al (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118:3160\u20133169","journal-title":"J Clin Invest"},{"key":"2274_CR22","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","volume":"120","author":"J Tam","year":"2010","unstructured":"Tam J, Vemuri VK, Liu J et al (2010) Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120:2953\u20132966","journal-title":"J Clin Invest"},{"key":"2274_CR23","unstructured":"Mancini G, Quarta C, Srivastava RK, Klaus S, Pagotto U, Lutz B (2010) Adipocyte-specific CB1 conditional knock-out mice: new insights in the study of obesity and metabolic syndrome. 20th Annual Symposium of the International Cannabinoid Research Society, July 23\u201327, Lund, Sweden"},{"key":"2274_CR24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00117769","volume":"4","author":"MJ Meredith","year":"1988","unstructured":"Meredith MJ (1988) Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture. Cell Biol Toxicol 4:405\u2013425","journal-title":"Cell Biol Toxicol"},{"key":"2274_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.2297","volume":"17","author":"A Bartelt","year":"2011","unstructured":"Bartelt A, Bruns OT, Reimer R et al (2011) Brown adipose tissue activity controls triacylglycerol clearance. Nat Med 17:200\u2013205","journal-title":"Nat Med"},{"key":"2274_CR26","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1073\/pnas.0812789106","volume":"106","author":"P Grimaldi","year":"2009","unstructured":"Grimaldi P, Orlando P, Di Siena S et al (2009) The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. Proc Natl Acad Sci U S A 106:11131\u201311136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2274_CR27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0021-9258(18)55987-1","volume":"191","author":"J Folch","year":"1951","unstructured":"Folch J, Ascoli I, Lees M, Meath JA, LeBaron N (1951) Preparation of lipid extracts from brain tissue. J Biol Chem 191:833\u2013841","journal-title":"J Biol Chem"},{"key":"2274_CR28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11745-008-3220-3","volume":"43","author":"L Scheja","year":"2008","unstructured":"Scheja L, Toedter K, Mohr R et al (2008) Liver TAG transiently decreases while PL n-3 and n-6 fatty acids are persistently elevated in insulin resistant mice. Lipids 43:1039\u20131051","journal-title":"Lipids"},{"key":"2274_CR29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/BF02535282","volume":"23","author":"JG Hamilton","year":"1988","unstructured":"Hamilton JG, Comai K (1988) Separation of neutral lipid, free fatty acid and phospholipid classes by normal phase HPLC. Lipids 23:1150\u20131153","journal-title":"Lipids"},{"key":"2274_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-2275(20)38861-1","volume":"27","author":"G Lepage","year":"1986","unstructured":"Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114\u2013120","journal-title":"J Lipid Res"},{"key":"2274_CR31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Wotjak CT, Azad SC et al (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530\u2013534","journal-title":"Nature"},{"key":"2274_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847\u2013853","journal-title":"Nature"},{"key":"2274_CR33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","volume":"51","author":"V Marzo Di","year":"2008","unstructured":"Di Marzo V (2008) The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 51:1356\u20131367","journal-title":"Diabetologia"},{"key":"2274_CR34","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P et al (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 91:3171\u20133180","journal-title":"J Clin Endocrinol Metab"},{"key":"2274_CR35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881\u2013887","journal-title":"Nature"},{"key":"2274_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.2009.00183.x","volume":"158","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Piscitelli F, Capasso R et al (2009) Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol 158:451\u2013461","journal-title":"Br J Pharmacol"},{"key":"2274_CR37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Osei-Hyiaman D, Park O et al (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7:227\u2013235","journal-title":"Cell Metab"},{"key":"2274_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tins.2011.03.003","volume":"34","author":"BE Alger","year":"2011","unstructured":"Alger BE, Kim J (2011) Supply and demand for endocannabinoids. Trends Neurosci 34:304\u2013315","journal-title":"Trends Neurosci"},{"key":"2274_CR39","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2337\/db07-1186","volume":"57","author":"TM D\u2019Eon","year":"2008","unstructured":"D\u2019Eon TM, Pierce KA, Roix JJ, Tyler A, Chen H, Teixeira SR (2008) The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 57:1262\u20131268","journal-title":"Diabetes"},{"key":"2274_CR40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.metabol.2008.10.009","volume":"58","author":"R Sarzani","year":"2009","unstructured":"Sarzani R, Bordicchia M, Marcucci P et al (2009) Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Metabolism 58:361\u2013367","journal-title":"Metabolism"},{"key":"2274_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2362.2009.02231.x","volume":"40","author":"MF Bennetzen","year":"2010","unstructured":"Bennetzen MF, Nielsen TS, Paulsen SK et al (2010) Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese. Eur J Clin Invest 40:121\u2013126","journal-title":"Eur J Clin Invest"},{"key":"2274_CR42","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M Bl\u00fcher","year":"2006","unstructured":"Bl\u00fcher M, Engeli S, Kl\u00f6ting N et al (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55:3053\u20133060","journal-title":"Diabetes"},{"key":"2274_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","volume":"52","author":"V Marzo Di","year":"2009","unstructured":"Di Marzo V, C\u00f4t\u00e9 M, Matias I et al (2009) Changes in plasma endocannabinoid levels in viscerally obese men following a 1\u00a0year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 52:213\u2013217","journal-title":"Diabetologia"},{"key":"2274_CR44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2010.01.003","volume":"52","author":"Y Akazawa","year":"2010","unstructured":"Akazawa Y, Cazanave S, Mott JL et al (2010) Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol 52:586\u2013593","journal-title":"J Hepatol"},{"key":"2274_CR45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbalip.2007.11.001","volume":"1781","author":"I Matias","year":"2008","unstructured":"Matias I, Carta G, Murru E, Petrosino S, Banni S, Di Marzo V (2008) Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim Biophys Acta 1781:52\u201360","journal-title":"Biochim Biophys Acta"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2274-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2274-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:34:51Z","timestamp":1638315291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2274-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}